This file is part of IDEAS, which uses RePEc data


[ Papers | Articles | Software | Books | Chapters | Authors | Institutions | JEL Classification | NEP reports | Search | New papers by email | Author registration | Rankings | Volunteers | FAQ | Blog | Help! ]

New Pills for Poor People? Empirical Evidence after GATT

Author info | Abstract | Publisher info | Download info | Related research | Statistics
Author Info
Lanjouw, Jean O.
Cockburn, Iain M.

Additional information is available for the following registered author(s):

Abstract

No abstract is available for this item.

Download Info
To download:

If you experience problems downloading a file, check if you have the proper application to view it first. Information about this may be contained in the File-Format links below. In case of further problems read the IDEAS help page. Note that these files are not on the IDEAS site. Please be patient as the files may be large.

File URL: http://www.sciencedirect.com/science/article/B6VC6-423RH42-4/2/3e273282c604ab0ba8e757fb1e52c36b
File Format:
File Function:
Download Restriction: Full text for ScienceDirect subscribers only

As the access to this document is restricted, you may want to look for a different version under "Related research" (further below) or search for a different version of it.

Publisher Info
Article provided by Elsevier in its journal World Development.

Volume (Year): 29 (2001)
Issue (Month): 2 (February)
Pages: 265-289
Download reference. The following formats are available: HTML (with abstract), plain text (with abstract), BibTeX, RIS (EndNote, RefMan, ProCite), ReDIF
Handle: RePEc:eee:wdevel:v:29:y:2001:i:2:p:265-289

Contact details of provider:
Web page: http://www.elsevier.com/locate/worlddev

For technical questions regarding this item, or to correct its listing, contact: (Heidi Boesdal).

Related research
Keywords:

Cited by:
(explanations, Please report citation or reference errors to , or , if you are the registered author of the cited work, log in to your RePEc Author Service profile, click on "citations" and make appropriate adjustments.)

  1. Michael Kremer, 2000. "Creating Markets for New Vaccines Part I: Rationale," NBER Working Papers 7716, National Bureau of Economic Research, Inc. [Downloadable!] (restricted)
    Other versions:
  2. Sunil Kanwar, 2002. "Does Intellectual Property Lead to Intellectual Property Protection?," Working papers 108, Centre for Development Economics, Delhi School of Economics. [Downloadable!]
  3. Iain M. Cockburn & Megan J. MacGarvie, 2006. "Entry, Exit and Patenting in the Software Industry," NBER Working Papers 12563, National Bureau of Economic Research, Inc. [Downloadable!] (restricted)
  4. Alexandre Almeida & Aurora A.C. Teixeira, 2008. "One size does not fit all… An economic development perspective on the asymmetric impact of Patents on R&D," FEP Working Papers 292, Universidade do Porto, Faculdade de Economia do Porto. [Downloadable!]
  5. Alka Chadha & Åke Blomqvist, 2005. "Patent Races, “Me-Too” Drugs, and Generics: A Developing-World Perspective," Departmental Working Papers wp0513, National University of Singapore, Department of Economics. [Downloadable!]
  6. Shubham Chaudhuri & Pinelopi K. Goldberg & Panle Jia, 2003. "The Effects of Extending Intellectual Property Rights Protection to Developing Countries: A Case Study of the Indian Pharmaceutical," Discussion Papers 0304-08, Columbia University, Department of Economics. [Downloadable!]
  7. Hernán Jaramillo Salazar & José Manuel Restrepo Abondano & Catalina Latorre Santos, 2003. "Mercado de Medicamentos, Regulación y Políticas Públicas," BORRADORES DE INVESTIGACIÓN 004328, UNIVERSIDAD DEL ROSARIO - FACULTAD DE ECONOMÍA. [Downloadable!]
  8. Abdulkadir Civan & Michael Maloney, 2006. "The Determinants of Pharmaceutical Research and Development Investments," Contributions to Economic Analysis & Policy, Berkeley Electronic Press, vol. 5(1), pages 1511-1511. [Downloadable!] (restricted)
  9. Shubham Chaudhuri & Pinelopi K. Goldberg & Panle Jia, 2003. "Estimating the Effects of Global Patent Protection in Pharmaceuticals: A Case Study of Quinolones in India," NBER Working Papers 10159, National Bureau of Economic Research, Inc. [Downloadable!] (restricted)
  10. Michael Kremer, 2000. "Creating Markets for New Vaccines Part II: Design Issues," NBER Working Papers 7717, National Bureau of Economic Research, Inc. [Downloadable!] (restricted)
    Other versions:
  11. Joan Ramon Borrell Arque, 2004. "Las patentes aceleran o retrasan la comercializacion de nuevos medicamentos en los paises en desarrollo?," Working Papers in Economics 122, Universitat de Barcelona. Espai de Recerca en Economia. [Downloadable!]
  12. Shubham Chaudhuri, 2006. "Estimating the Effects of Global Patent Protection in Pharmaceuticals: A Case Study of Quinolones in India," Working Papers id:772, esocialsciences.com. [Downloadable!]
  13. Sudip Chaudhuri, 2009. "R and D for Development of New Drugs for Neglected Diseases How Can India Contribte?," Working Papers id:2149, esocialsciences.com. [Downloadable!]
Statistics
Access and download statistics

Did you know? Springer Verlag was the first commercial publisher to be listed on RePEc.

This page was last updated on 2009-11-7.


This information is provided to you by IDEAS at the Department of Economics, College of Liberal Arts and Sciences, University of Connecticut using RePEc data on a server sponsored by the Society for Economic Dynamics.